{
    "xml": "<topic id=\"PHP4362\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/deflazacort\" basename=\"deflazacort\" title=\"DEFLAZACORT\">\n<title>DEFLAZACORT</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_489\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/deflazacort\">Deflazacort</xref>\n</p>\n<data name=\"vtmid\">116578002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" namespace=\"/drug-classes/corticosteroids-systemic\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP43656\" outputclass=\"indicationsAndDose\" rev=\"1.43\" parent=\"/drugs/deflazacort\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Suppression of inflammatory and allergic disorders</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Maintenance 3&#8211;18&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Suppression of inflammatory and allergic disorders (acute disorders)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially up to 120&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Inflammatory and allergic disorders</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years</p>\n<p>Maintenance 0.25&#8211;1.5&#8239;mg/kg once daily or on alternate days; increased if necessary up to 2.4&#8239;mg/kg daily (max. per dose 120&#8239;mg), in emergency situations.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 3&#8211;18&#8239;mg once daily or on alternate days; increased if necessary up to 2.4&#8239;mg/kg daily (max. per dose 120&#8239;mg), in emergency situations.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43626\" outputclass=\"renalImpairment\" parent=\"/drugs/deflazacort\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43629\" outputclass=\"patientAndCarerAdvice\" rev=\"1.10\" parent=\"/drugs/deflazacort\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patient counselling is advised for deflazacort tablets (steroid card).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4362-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/deflazacort\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: tablet</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75724\" title=\"Tablet\" namespace=\"/drugs/deflazacort/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78288\" namespace=\"/treatment-summaries/glucocorticoid-therapy\" title=\"Glucocorticoid therapy\" count=\"1\" rel=\"backlink\">Glucocorticoid therapy</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_489\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/deflazacort\" title=\"Deflazacort\" count=\"1\" rel=\"link\">Deflazacort</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" namespace=\"/drug-classes/corticosteroids-systemic\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75724\" namespace=\"/drugs/deflazacort/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP4362",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/deflazacort",
    "basename": "deflazacort",
    "title": "DEFLAZACORT",
    "interactants": [
        {
            "id": "bnf_int_489",
            "label": "Deflazacort"
        }
    ],
    "vtmid": "116578002",
    "drugClassification": [
        "Corticosteroids"
    ],
    "inheritsFromClass": [
        "CORTICOSTEROIDS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Suppression of inflammatory and allergic disorders",
                        "html": "Suppression of inflammatory and allergic disorders"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Maintenance 3&#8211;18 mg daily.",
                        "html": "<p>Maintenance 3&#8211;18&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Suppression of inflammatory and allergic disorders (acute disorders)",
                        "html": "Suppression of inflammatory and allergic disorders (acute disorders)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially up to 120 mg daily.",
                        "html": "<p>Initially up to 120&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Inflammatory and allergic disorders",
                        "html": "Inflammatory and allergic disorders"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Maintenance 0.25&#8211;1.5 mg/kg once daily or on alternate days; increased if necessary up to 2.4 mg/kg daily (max. per dose 120 mg), in emergency situations.",
                        "html": "<p>Maintenance 0.25&#8211;1.5&#8239;mg/kg once daily or on alternate days; increased if necessary up to 2.4&#8239;mg/kg daily (max. per dose 120&#8239;mg), in emergency situations.</p>",
                        "ageGroup": "1 month&#8211;11 years"
                    },
                    {
                        "textContent": "Initially 3&#8211;18 mg once daily or on alternate days; increased if necessary up to 2.4 mg/kg daily (max. per dose 120 mg), in emergency situations.",
                        "html": "<p>Initially 3&#8211;18&#8239;mg once daily or on alternate days; increased if necessary up to 2.4&#8239;mg/kg daily (max. per dose 120&#8239;mg), in emergency situations.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ]
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patient counselling is advised for deflazacort tablets (steroid card).",
                "html": "<p>Patient counselling is advised for deflazacort tablets (steroid card).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "tablet"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75724",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78288",
                "label": "Glucocorticoid therapy",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_489",
                "label": "Deflazacort",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34623",
                "label": "CORTICOSTEROIDS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75724",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}